Cerebrovascular event after TAVI - predictors and prevention

Session comprising selected EuroPCR 2019 abstract submissions

Chairperson: L. N. Hopkins
SHOW MORE

Summary

Consult this session to discover various studies and meta-analysis related to cerebrovascular event after TAVI, and learn more about how to predict and prevent it.

Presentations available when logged in:

  • LAA thrombus and TAVI: prevalence and clinical outcome
  • Platelet inhibition affects high-intensity transient signals to cerebral circulation during TAVI
  • Outcomes in patients with pre-existing atrial fibrillation undergoing TAVI
  • Incidence and outcomes of bioprosthetic valve thrombosis after surgical and TAVR: a meta-analysis
  • Comparison of subclinical leaflet thrombus between TAVI vs. AVR in early acute phases
  • Single low-dose apixaban vs. single acenocoumarol in patients with atrial fibrillation after TAVI. A propensity score-matched analysis
  • Safety and efficacy of TAVR with continuation of vitamin K antagonist or direct oral anticoagulant